NCT04523142 - CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004 | Biotech Hunter

Enrollment

202

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

May 23, 2022

Conditions

Dry Eye Disease (DED)

Interventions

DRUG

CyclASol Ophthalmic Solution

Cyclosporine A solution in vehicle

Trial Locations (14)

CYS-005 Investigational Site, Cranberry Township

CYS-005 Investigational Site, Lynchburg

CYS-005 Investigational Site, Raleigh

CYS-005 Investigational Site, Shelby

CYS-005 Investigational Site, Memphis

CYS-005 Investigational Site, Louisville

CYS-005 Investigational Site, Carmel

CYS-005 Investigational Site, Fargo

CYS-005 Investigational Site, Layton

CYS-005 Investigational Site, Henderson

CYS-005 Investigational Site, Los Angeles

CYS-005 Investigational Site, Newport Beach

CYS-005 Investigational Site, Andover

CYS-005 Investigtional Site, Raynham